• PDF / 169,141 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 77 Downloads / 131 Views

DOWNLOAD

REPORT

---

1 S

Upper gastrointestinal bleeding: case report In a prospective study conducted between May 2017 and February 2018, in which 88 patients with decompensated liver cirrhosis with virus C (LC VC) were admitted to a hospital in Romania, one patient [age and sex not stated] was described, who developed upper gastrointestinal bleeding during treatment with ledipasvir/sofosbuvir and ribavirin. The patient, who had LC VC, started receiving treatment with oral ledipasvir/sofosbuvir and ribavirin [dosages not stated]. However, the patient developed upper gastrointestinal bleeding [duration of treatment to reaction onset not stated], requiring emergency hospitalisation. Therefore, therapy with ledipasvir/sofosbuvir and ribavirin was discontinued [outcome not stated]. Cuciureanu T, et al. Cessation of oral antiviral treatment in patients with decompensated liver cirrhosis with virus C. Journal of Gastrointestinal and Liver Diseases 27 (Suppl. 803497671 2): 50-51, May 2018. Available from: URL: https://www.jgld.ro/jgld/index.php/jgld [abstract]

0114-9954/20/1818-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 22 Aug 2020 No. 1818